This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gorenstein, C. Articles by Lauriano, V. Search for Related Content PubMed PubMed Citation Articles by Gorenstein, C. Articles by Lauriano, V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PROPANTHELINE Social Bookmarking                         What's this?

Mood improvement in 'normal' volunteers

Departamento de Farmacologia, Instituto de Ciências Biomédicas, LIM-23, Departamento de Psiquiatria, Faculdade de Medicina

Valentim Gentil

LIM-23, Departamento de Psiquiatria, Faculdade de Medicina, Instituto de Psiquiatria, Hospital das Clinicas, Universidade de Sào Paulo, Brazil

Marcio Melo

LIM-23, Departamento de Psiquiatria, Faculdade de Medicina

Francisco Lotufo-Neto

Instituto de Psiquiatria, Hospital das Clinicas, Universidade de Sào Paulo, Brazil

Valéria Lauriano

LIM-23, Departamento de Psiquiatria, Faculdade de Medicina

To test the hypothesis that clomipramine is effective in improving subthreshold non-specific symptoms in subjects without any established psychopathology, we conducted a double-blind, cross-over controlled trial of clomipramine (oral doses of 10-40 mg/day) and propanteline (active placebo) for 5 weeks in nine normal volunteers. Four other subjects completed the first part of the trial. These subjects were selected from 275 respondents to newspaper and radio requests for subjects who considered themselves as normal but were unhappy about their usual moods. They did not reach cut-off scores in the Self-Report Questionnaire and did not meet diagnostic criteria for any lifetime or current ICD-10 or DSM-III-R condition, as assessed by an open psychiatric interview and the Schedules for Clinical Assessment in Neuropsychiatry. Despite the small sample and the low level of initial symptomatology, both subjects and observers consistently detected significant improvements with clomipramine in a number of assessments of mood, notably decreased irritability and anxiety. This controlled trial suggests that it is possible to improve subclinical complaints through psychopharmacological agents, raises questions about the mechanisms of their action and discusses their implications.

Key Words: clinical trial • clomipramine • irritability • mood • normal volunteers

Journal of Psychopharmacology, Vol. 12, No. 3, 246-251 (1998)
DOI: 10.1177/026988119801200303


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?